The Food and Drugs Administration (FDA), Maharashtra, has issued a strict prohibition order on two cough syrup brands, Respifresh TR and Relife, after laboratory tests confirmed the presence of Diethylene Glycol (DEG) impurities beyond the safe limit.
These syrups, manufactured by Rednex Pharmaceuticals Pvt. Ltd. and Shape Pharma Pvt. Ltd. in Gujarat, were declared adulterated and not of standard quality. Diethylene Glycol is a toxic chemical that can cause severe poisoning, kidney damage, and even death, especially in children. Under Section 18 of the Drugs and Cosmetics Act, 1940, the sale, distribution, and use of these products are completely banned across Maharashtra.
All retailers, distributors, hospitals, and medical practitioners must immediately stop the sale of these batches and report any existing stock to local FDA offices. This action reinforces Maharashtra’s commitment to ensuring drug safety and public health protection.